Cargando…
Follow-up on the therapeutic effects of a budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regimen in children with post-infectious bronchiolitis obliterans
BACKGROUND: Post-infectious bronchiolitis obliterans (PIBO) is a rare, severe chronic lung disease without optimal treatment. Currently, treatment in children mainly relies on systemic corticosteroids, but long-term use of these drugs may lead to adverse reactions. This study aimed to evaluate the s...
Autores principales: | Weng, Tingting, Lin, Xixi, Wang, Leying, Lv, Jiamei, Dong, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411176/ https://www.ncbi.nlm.nih.gov/pubmed/34527318 http://dx.doi.org/10.21037/jtd-20-3195 |
Ejemplares similares
-
Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children
por: Chen, Xia, et al.
Publicado: (2020) -
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
por: Kim, Sei Won, et al.
Publicado: (2016) -
LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats
por: Tu, Zheng-Liang, et al.
Publicado: (2017) -
Long-term effect of azithromycin in bronchiolitis obliterans syndrome
por: Gan, C.Tji-Joong, et al.
Publicado: (2019) -
Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial
por: Ruttens, David, et al.
Publicado: (2018)